Leppert

Italy Spain Switzerland
|
2022-2024
  • Adults
  • Elderly
  • General population
  • Outpatient clinic
  • SARS-CoV-2
  • Post-COVID-19
  • Pharmacological intervention
  • Temelimab
  • Monoclonal antibodies